Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

Caitlin E. Cox

December 28, 2023

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

News Daily News

‘Mother Ships’ and Helicopters: Speed Is Key for Rural Stroke Thrombectomy

Todd Neale

May 11, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Todd Neale

June 23, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Featured Fellow

Mahesh Anantha, MD

Yael L. Maxwell

October 12, 2020

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2025

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

May 2025 Dispatch for the CV Team

September 2024 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

TCTMD’s Top 10 Most Popular Stories for December 2023

High-Sensitivity Troponins May Overestimate PE Severity

What’s Going to Be Hot at AHA 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

‘Mother Ships’ and Helicopters: Speed Is Key for Rural Stroke Thrombectomy

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Mahesh Anantha, MD

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content